Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
ACS Applied Materials & Interfaces|June 7, 2018
Reactive B/Ti Nano-Multilayers with Superior Performance in Plasma GenerationYuxin Zhang, Yao Wang, Mengting Ai, et al.Zhonghua Yi Xue Za Zhi|October 15, 2014
[Role of magnetic resonance imaging for response evaluation and predictive value of tumor biomarkers in the neoadjuvant chemotherapy for breast cancer:a multi-center prospective study]Ling Xin, Qian Liu, Ling Xu, et al.Sensors (Basel, Switzerland)|January 6, 2018
Integrated Temperature and Hydrogen Sensors with MEMS TechnologyHongchuan Jiang, Min Huang, Yibing Yu, et al.Frontiers in Oncology|November 1, 2021
Predicting Axillary Lymph Node Metastasis in Early Breast Cancer Using Deep Learning on Primary Tumor Biopsy SlidesFeng Xu, Chuang Zhu, Wenqi Tang, et al.Polymers|April 10, 2019
High-Performance TiO₂ Nanotubes/Poly(aryl ether sulfone) Hybrid Self-Cleaning Anti-Fouling Ultrafiltration MembranesZhi Geng, Xinyu Wang, Hongchuan Jiang, et al.Cancer Biology & Medicine|March 30, 2026
Virtual histology imaging of lymph nodes <i>via</i> dynamic full-field optical coherence tomography and deep learning to differentiate metastasisShuwei Zhang, Houpu Yang, Yiyin Zhang, et al.Journal of Surgical Oncology|September 28, 2018
Comparison of surgical complication between immediate implant and autologous breast reconstruction after mastectomy: A multicenter study of 426 casesFeng Xu, Haihui Sun, Chao Zhang, et al.Medicine|June 3, 2020
Patient satisfaction in one-stage immediate breast reconstruction after mastectomy: A multi-center comparative patient evaluation of prosthesis, LDMF, and TRAM techniquesChuqi Lei, Lijie Xu, Feng Xu, et al.Chinese Medical Journal|July 3, 2014
Multicenter prospective study of magnetic resonance imaging prior to breast-conserving surgery for breast cancerQian Liu, Yinhua Liu, Ling Xu, et al.Clinical Drug Investigation|October 9, 2025
Efbemalenograstim Alfa, an Fc Fusion Protein, Long‑Acting Granulocyte Colony-Stimulating Factor for Reducing the Risk of Chemotherapy-Induced Neutropenia: Results of a Phase II Randomized, Multicenter, Open‑Label TrialDongmei Ji, Shufang Wang, Wei Yao, et al.Pageof 6